Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
3.08 -0.03  (-0.96%)
TradingVolume：883.1
11-24
2025
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03017 FOR CLINICAL TRIALS IN THE U.S.
Publisher：
11-21
2025
DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
Publisher：
11-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Publisher：
10-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Publisher：
09-29
2025
Interim Report 2025
Publisher：
09-10
2025
Next Day Disclosure Return
Publisher：
09-10
2025
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
09-09
2025
Next Day Disclosure Return
Publisher：
09-09
2025
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
09-03
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：883.1
3.08
-0.03  (-0.96%)
Announcement & Circular
11-24
2025
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03017 FOR CLINICAL TRIALS IN THE U.S.
11-21
2025
DISCLOSEABLE TRANSACTION ISSUE OF EXCHANGEABLE PREFERENCE SHARES BY A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY
11-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
10-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
09-29
2025
Interim Report 2025
09-10
2025
Next Day Disclosure Return
09-10
2025
OVERSEAS REGULATORY ANNOUNCEMENT
09-09
2025
Next Day Disclosure Return
09-09
2025
OVERSEAS REGULATORY ANNOUNCEMENT
09-03
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
First
1
2
3
4
5
Last